LivaNovaLIVN +1.40%76 OCF Margin % is 4.20% as of Mar. 2026, which is 54% below its 10-year median of 9.18. GuruFocus rates LIVN with a GF Score™ of 76/100 and a GF Value™ of $62.48 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, LivaNova ranks better than 73.01% on this metric.
The historical rank and industry rank for LivaNova's OCF Margin % or its related term are showing as below:
LIVN'
s OCF Margin % Range Over the Past 10 Years
Min: -8.5 Med: 9.18 Max: 18.32
Current: 17.13
During the past 13 years, the highest OCF Margin % of LivaNova was 18.32%. The lowest was -8.50%. And the median was 9.18%.
LIVN's OCF Margin % is ranked better than 73.01% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs LIVN: 17.13
LivaNova OCF Margin % Related Terms
LivaNova OCF Margin % Historical Data
* Premium members only.
The historical data trend for LivaNova's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LivaNova's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LivaNova OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's OCF Margin % distribution charts can be found below:
* The bar in red indicates where LivaNova's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LivaNova (LIVN) has a OCF Margin % of 4.20% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on LivaNova and its competitors. This is 54% below median its historical median of 9.18. According to the industry distribution chart, LivaNova ranks #220 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 27%.
Is LivaNova's OCF Margin % too high?
LivaNova's current OCF Margin % of 4.20% is 54% below median its 10-year median of 9.18. The Medical Devices & Instruments industry median OCF Margin % is 5.86. LivaNova's value of 4.20% is 28.3% below this industry median. Based on the distribution chart, LivaNova ranks #220 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, LivaNova has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LivaNova's OCF Margin % compare to IRTC and HAE?
According to the Medical Devices & Instruments industry distribution chart, LivaNova ranks #220 out of 815 companies for OCF Margin %. This puts LivaNova in the upper half of its industry. The industry median OCF Margin % is 5.86. LivaNova's value of 4.20% is 28.3% below this benchmark. While the company's 10-year median is 9.18 vs. the industry median of 5.86, LivaNova has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LivaNova's current OCF Margin % of 4.20% is 28.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on LivaNova and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LivaNova's current OCF Margin % is 4.20%, which is 54% below median its own 10-year median of 9.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LivaNova stock overvalued right now?
Based on GuruFocus' analysis, LivaNova (LIVN) is currently considered Modestly Overvalued. The stock's GF Value™ is $62.48, compared to a current price of $81.05 — trading 29.7% above its estimated fair value. The current OCF Margin % is 4.20%, which is 54% below median its 10-year median of 9.18 and 28.3% below the Medical Devices & Instruments industry median of 5.86. LivaNova's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For LivaNova (LIVN), the current OCF Margin % is 4.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LivaNova (LIVN) Overvalued in 2026?
Based on GuruFocus' analysis, LivaNova stock appears to be overvalued.
The current stock price of $81.05 is trading 29.7% above its estimated GF Value™ of $62.48.
GuruFocus considers LivaNova to be Modestly Overvalued.
Key valuation signals for LIVN:
OCF Margin %: 4.20% (54% below median its 10-year median of 9.18)
GF Value™: $62.48 vs. price of $81.05 (29.7% above fair value)
Industry Position: 28.3% below the Medical Devices & Instruments median (#220 of 815)
No single metric tells the full story. See the LIVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
76GF Score
Get the complete analysis for LIVN
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LIVN has been successfully added to your 
